Active Ingredient History

NOW
  • Now
Oxybuprocaine (benoxinate) hydrochloride (MINIMSĀ®) is a local, surface anaesthetic of the ester type. It has been shown to give effective surface anaesthesia in short opthalmological procedures. Sensation of pain is locally and reversibly reduced, with the possibility of temperature and pressure sensitivity also affected. Anaesthetic activity is ten times that of cocaine and twice that of tetracaine (amethocaine). Oxybuprocaine (benoxinate) binds to sodium channel and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions. Depolarization of the neuronal membrane is inhibited thereby blocking the initiation and conduction of nerve impulses.   NCATS

More Chemistry

Combination drugs

( fluorescein, benoxinate )
4-amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid | 4-amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester | 4-amino-3-n-butoxy-benzoesaeure-diaethylaminoaethylester | benoxil | benoxinate | benoxinate dihydrochloride | benoxinate hcl | benoxinate hydrochloride | benoxinate monohydrochloride | bnx | butoxyaminobenzoyldiethylaminoethanol | butoxyprocaine | diethylaminoethyl-4-amino-3-butoxybenzoate | dorsecaine | novescine | novesin | oxibuprocaina | oxibuprocaine chloride | oxybucaine | oxybuprocaine | oxybuprocaine hcl | oxybuprocainum | oxyriprocaine

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue